Chemotherapy versus allogeneic or autologous bone marrow transplantation in second complete remission of acute lymphoblastic leukemia

Related Experiment Videos

P Herve¹, P Bordigoni, E Plouvier

¹Bone Marrow Unit, Besançon, France.

|November 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

Leukemia·2015

Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Bone marrow transplantation·2013

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.

Bone marrow transplantation·2012

Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2011

Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011

Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.

International journal of laboratory hematology·2011

See all related articles